North American CDMO Trillium Health Care Products is a North American contract development and manufacturing organization (CDMO) with cGMP-compliant facilities in Ontario, enabling regulated production for both FDA and Health Canada markets. This positions them well for brands seeking cross-border manufacturing and streamlined North American distribution.

Broad Formulation Capabilities With experience across non-sterile liquids, semi-solids, solids, and integrated packaging, Trillium can handle end-to-end development to commercial production for OTCs, vitamins, minerals, and consumer health products, offering a single source for formulation, manufacturing, and packaging.

Scale-Up Expertise Their focus on risk areas such as scale-up from development to commercial production and packaging/formulation compatibility highlights opportunities to partner on early-stage development, optimization, and stability testing for faster market entry.

Strategic Acquisition Access Recent acquisition by Avista Healthcare Partners suggests strong financial backing and growth potential, which can be leveraged to pursue strategic collaborations, capacity expansion projects, or co-development opportunities with brands seeking scale and investment.

Revenue Range & Market Fit With estimated revenue between $50M-$100M and a track record as a trusted manufacturing partner to leading brands across North America, Trillium presents opportunities to target mid-market OTC and consumer health brands seeking reliable CDMO capabilities and cross-border regulatory expertise.